Dr. Agarwal's Health Care Limited ('the Company') has made a regulatory disclosure pursuant to Regulation 30 of the SEBI Listing Regulations and SEBI Master Circular no. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026.

The company executed a binding Media Agreement with GoodEdge Advisory Private Limited on November 16, 2026. The purpose of the agreement is the engagement of media, branding, public relations (PR), strategic communications, and marketing execution services.

Key Agreement Details:

  • Parties: Dr. Agarwal's Health Care Limited and The GoodEdge Advisory Private Limited
  • Shareholding: The company holds no shareholding in GoodEdge Advisory Private Limited
  • Special Rights: The agreement does not create any special rights including (i) right to appoint directors, (ii) right to share subscription, or (iii) right to restrict capital structure changes
  • Related Party Status: The parties are not related to promoter/promoter group/group companies
  • Related Party Transaction: The transaction does not qualify as a related party transaction
  • Share Issuance: No shares are being issued pursuant to this agreement
  • Additional Disclosures: No nominee director appointments, potential conflicts of interest, or other significant disclosures

The disclosure was filed with both BSE Limited and National Stock Exchange of India Limited. The information has also been made available on the company's website at www.dragarwals.co.in.

The disclosure was signed by Thanikainathan Arumugam, Company Secretary and Compliance Officer, on November 16, 2026 at 19:15:52 IST.

Financial Impact: The disclosure does not quantify any financial impact of the agreement.

Regulatory Reference: This disclosure is made under Regulation 30(2) read with Sub Clause 5 of Part A, Para A of Schedule III of the SEBI Listing Regulations.